Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

361.73B

Market cap361.73B

Price-Earnings ratio

149.85

Price-Earnings ratio149.85

Dividend yield

2.32%

Dividend yield2.32%

Average volume

10.41M

Average volume10.41M

High today

$147.48

High today$147.48

Low today

$142.80

Low today$142.80

Open price

$143.95

Open price$143.95

Volume

7.63M

Volume7.63M

52 Week high

$156.92

52 Week high$156.92

52 Week low

$85.24

52 Week low$85.24

Stock Snapshot

With a market cap of 361.73B, Merck(MRK) trades at $146.75. The stock has a price-to-earnings ratio of 149.85 and currently yields dividends of 2.32%.

As of 2026-11-07, Merck(MRK) stock has fluctuated between $142.80 and $147.48. The current price stands at $146.75, placing the stock +2.8% above today's low and -0.5% off the high.

The Merck(MRK)'s current trading volume is 7.63M, compared to an average daily volume of 10.41M.

During the past year, Merck(MRK) stock moved between $85.24 at its lowest and $156.92 at its peak.

MRK News

Zacks 1d

Merck Stock Shows Sustained Strength: Time to Buy, Sell or Hold?

Merck’s (MRK Quick QuoteMRK - Free Report) stock has been trading above its 200-day simple moving average (SMA) for over a year now, while it moved above...

Simply Wall St 1d

Merck Posts Phase 3 Cancer Wins In Endometrial Disease And Melanoma

Merck (NYSE:MRK) reported new Phase 3 data for oncology programs including KEYTRUDA and an mRNA melanoma therapy on 5 November 2026. KEYNOTE-C93 showed KEYTRUD...

24/7 Wall St. 4d

Merck's Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.

Investing Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue. Merck just posted its sixth straight earnings beat and its CEO...

Analyst ratings

70%

of 30 ratings

Buy

70%

Hold

26.7%

Sell

3.3%

More MRK News

Simply Wall St 7d

Merck Stock Still Looks Like A Bargain On Its 113% Run

has been a strong performer in recent years, and with fresh oncology data and new treatments moving through regulators, the question now is whether the current...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

WisdomTree Japan Hedged E…

Cadence Design Systems

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.